Back

Characterizing the Effects of Chronic Cannabis Vapour Exposure and Withdrawal on Cannabinoid Triad, Somatic Signs and Behavioural Network Reorganization Adult Male Rats

Albeely, A. M.; Kayir, H.; Quansah Amissah, R.; Zali, B.; Karahan, S.; Smith, J.; Ibrahim, A. A.; Hassan, A.; Hussein, S.; Frie, J. A.; Khokhar, J.

2026-06-17 neuroscience
10.64898/2026.06.12.731896 bioRxiv
Show abstract

RationaleCannabis withdrawal contributes to relapse in individuals with cannabis use disorder, yet preclinical studies have largely focused on withdrawal induced by injected cannabinoids rather than inhaled cannabis, which remains the most common route in humans. The behavioural effects of chronic exposure to vapourized cannabis flower and resulting withdrawal after cessation of exposure remain poorly characterized. ObjectivesTo determine the behavioural effects of chronic vapourized high-THC cannabis flower exposure on cannabinoid tetrad, somatic withdrawal and behavioural transition networks in rats following both chronic vapour exposure and administration of the cannabinoid receptor 1 (CB1) receptor antagonist SR141716A (rimonabant). MethodsTwo studies were conducted using adult male Sprague Dawley rats. The first study (N = 16) exposed rats to either air or vapourized high-THC cannabis flower three times a day for seven days using a Volcano vapourizer, followed by intraperitoneal administration of the CB1 antagonist SR141716A (3 mg/kg). The second study (N = 24) included two air controls and two cannabis groups, with one of each receiving either saline or SR141716A. Behavioural assessments included triad measurements to confirm the cannabis effect, along with withdrawal assessment via a sucrose preference test and somatic signs 30 minutes following rimonabant administration. ResultsRepeated cannabis vapour exposure produced reduced locomotor activity, hypothermia, and increased tail-flick latency. Rimonabant administration precipitated withdrawal characterized by increased total withdrawal scores and somatic signs, including blinking, body shakes/tremors, and grooming-related behaviours. Behavioural network analyses revealed substantial reorganization of behavioural transition structure during both chronic cannabis exposure and withdrawal. Chronic cannabis exposure was associated with reduced network modularity, a condensed behavioural repertoire, and altered behavioural centrality measures. At the same time, precipitated withdrawal further increased the influence of exploratory behaviours, particularly sniffing, and reduced the network prominence of locomotor-associated behaviours, such as walking, beyond that detected using conventional behavioural measures alone. ConclusionChronic exposure to vapourized cannabis flower followed by CB1 receptor antagonism produces reliable withdrawal symptoms in rats. Behavioural network analyses further reveal that cannabis exposure and withdrawal are both associated with widespread reorganization of behavioural dynamics, suggesting that withdrawal alters not only individual behaviours but also the structure of behavioural transitions. These findings establish a translational model of cannabis withdrawal using inhaled cannabis flower vapour and identify behavioural network analysis as a sensitive approach for characterizing withdrawal-related behavioural states.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Neuropsychopharmacology
153 papers in training set
Top 0.1%
19.1%
2
Psychopharmacology
69 papers in training set
Top 0.1%
11.4%
3
Neuropharmacology
68 papers in training set
Top 0.1%
11.0%
4
Translational Psychiatry
260 papers in training set
Top 1%
4.5%
5
Addiction Biology
51 papers in training set
Top 0.2%
4.5%
50% of probability mass above
6
Scientific Reports
3612 papers in training set
Top 31%
3.4%
7
eneuro
439 papers in training set
Top 2%
3.4%
8
Drug and Alcohol Dependence
41 papers in training set
Top 0.2%
2.9%
9
Molecular Psychiatry
282 papers in training set
Top 2%
2.9%
10
Behavioural Brain Research
77 papers in training set
Top 0.5%
2.7%
11
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.1%
2.5%
12
Psychological Medicine
88 papers in training set
Top 1.0%
2.2%
13
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 0.3%
2.2%
14
PLOS ONE
5266 papers in training set
Top 46%
2.0%
15
British Journal of Pharmacology
40 papers in training set
Top 0.4%
1.7%
16
Journal of Psychopharmacology
17 papers in training set
Top 0.2%
1.6%
17
European Neuropsychopharmacology
20 papers in training set
Top 0.2%
1.6%
18
The Journal of Neuroscience
1025 papers in training set
Top 8%
1.4%
19
International Journal of Neuropsychopharmacology
14 papers in training set
Top 0.2%
1.4%
20
American Journal of Psychiatry
24 papers in training set
Top 0.4%
1.2%
21
Biological Psychiatry
137 papers in training set
Top 2%
1.0%
22
Nicotine & Tobacco Research
12 papers in training set
Top 0.1%
0.9%
23
Frontiers in Behavioral Neuroscience
49 papers in training set
Top 0.8%
0.9%
24
Addiction Neuroscience
17 papers in training set
Top 0.4%
0.6%
25
Addiction
30 papers in training set
Top 0.5%
0.6%
26
Toxicological Sciences
41 papers in training set
Top 0.6%
0.5%
27
American Journal of Preventive Medicine
11 papers in training set
Top 0.4%
0.5%
28
Biological Psychiatry Global Open Science
60 papers in training set
Top 2%
0.5%
29
Nicotine and Tobacco Research
13 papers in training set
Top 0.2%
0.5%